Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Biostatistics: Overview01:20

Biostatistics: Overview

Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rheumatoid factor and anticitrullinated protein antibody status jointly influence the association between disease activity and cardiovascular risk in rheumatoid arthritis.

RMD open·2026
Same author

Integrating ethical analysis in health technology assessment: opportunities and challenges.

International journal of technology assessment in health care·2026
Same author

Sex and anticitrullinated protein antibodies modify the relationship between inflammation and cardiovascular risk in rheumatoid arthritis.

RMD open·2026
Same author

Critical Dynamics in the Association Cortex Predict Higher Intelligence in Typically Developing Children.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2026
Same author

Different operationalizations of the capability approach in evaluating rehabilitation for persons with neuromuscular diseases: a mixed-methods study.

Disability and rehabilitation·2025
Same author

Effectiveness of the capability approach in rehabilitation for persons with neuromuscular diseases: A controlled before-after study.

PloS one·2025

Related Experiment Video

Updated: Jun 3, 2026

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

Bridging the gap between aggregate data and individual patient management: a Bayesian approach.

Gert Jan van der Wilt1, Hans Groenewoud, Piet van Riel

  • 1Department of Epidemiology, Biostatistics, and Health Technology Assessment, Radboud University Medical Centre, Nijmegen, The Netherlands. G.vanderwilt@ebh.umcn.nl

International Journal of Technology Assessment in Health Care
|April 9, 2011
PubMed
Summary

Bayesian reasoning effectively applies to therapeutic questions, similar to diagnostics. This approach aids in managing individual rheumatoid arthritis patients by updating treatment response probabilities using clinical data.

More Related Videos

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Related Experiment Videos

Last Updated: Jun 3, 2026

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Area of Science:

  • Rheumatology
  • Biostatistics
  • Clinical Decision-Making

Background:

  • Bayesian reasoning is widely used in diagnostics.
  • Its application to therapeutic questions remains less explored.
  • Effective therapeutic decision-making requires integrating patient-specific data with existing evidence.

Purpose of the Study:

  • To investigate the applicability of Bayesian reasoning to therapeutic questions.
  • To assess its compatibility with diagnostic applications.
  • To bridge the gap between aggregate data and individual patient management.

Main Methods:

  • Formulated a therapeutic question for newly diagnosed rheumatoid arthritis (RA) management.
  • Estimated prior probabilities of methotrexate (MTX) response from literature.
  • Calculated likelihood ratios using Health Assessment Questionnaire (HAQ) changes as a marker, with Disease Activity Score (DAS) as gold standard.
  • Applied Bayes' theorem to calculate posterior probabilities of treatment response.

Main Results:

  • The prior probability of RA patient response to MTX was estimated at 45% from literature.
  • After three months, this probability adjusted to 80% or 23% based on observed HAQ score changes.
  • Demonstrated a quantifiable shift in treatment response probability.

Conclusions:

  • Bayesian reasoning is conceptually compatible with diagnostic applications when applied to therapeutic issues.
  • This methodology can effectively bridge aggregate data and individual patient care.
  • Facilitates personalized treatment strategies in rheumatology.